Second-Line Therapy

Second-line therapy is the treatment given when the first treatment, called first-line therapy, stops working or wasn't tolerated. In mesothelioma, it's the next set of options after the initial chemotherapy or other therapy no longer controls the disease. The choice depends on what was used first, how the cancer responded, and the patient's overall health.

Origin

The "line of therapy" concept comes from oncology's structured, sequential approach to cancer treatment, in which regimens are ordered by when they're tried. The terminology became standard as multiple drug options developed across the late 20th century.

Significance in Asbestos Context

For a mesothelioma patient, reaching second-line therapy usually means the first treatment has stopped holding the cancer back, an important moment to discuss goals and options with your oncologist. Options may include immunotherapy, a clinical trial, a different chemotherapy, or a rechallenge with the original drugs if there was a long response. What treatments you receive and when are documented in your medical records, and that treatment timeline can matter when a claim accounts for the cost and course of your care.

Example Sentence

After the pemetrexed and cisplatin stopped working, his oncologist discussed second-line therapy, including an immunotherapy clinical trial.

Related Terms

First-Line Therapy, Chemotherapy, Immunotherapy, Clinical Trial, Palliative Care, Mesothelioma Specialist

Notes

• Ask your oncologist whether a clinical trial is an option before starting standard second-line drugs; some trials require you not to have had certain prior treatments.
• Request that each line of therapy, with dates and responses, be clearly documented in your records.
• Ask whether tumor genetic or biomarker testing could point to additional treatment options.